184 related articles for article (PubMed ID: 35797877)
1. An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT).
Baimukhanova A; Engudar G; Marinov G; Kurakina E; Dadakhanov J; Karaivanov D; Yang H; Ramogida CF; Schaffer P; Magomedbekov EP; Filosofov D; Radchenko V
Nucl Med Biol; 2022; 112-113():35-43. PubMed ID: 35797877
[TBL] [Abstract][Full Text] [Related]
2. Application of ion exchange and extraction chromatography to the separation of actinium from proton-irradiated thorium metal for analytical purposes.
Radchenko V; Engle JW; Wilson JJ; Maassen JR; Nortier FM; Taylor WA; Birnbaum ER; Hudston LA; John KD; Fassbender ME
J Chromatogr A; 2015 Feb; 1380():55-63. PubMed ID: 25596759
[TBL] [Abstract][Full Text] [Related]
3. Production of
Friend MT; Mastren T; Parker TG; Vermeulen CE; Brugh M; Birnbaum ER; Nortier FM; Fassbender ME
Appl Radiat Isot; 2020 Feb; 156():108973. PubMed ID: 31727509
[TBL] [Abstract][Full Text] [Related]
4. Construction of a thorium/actinium generator at the Canadian Nuclear Laboratories.
Perron R; Gendron D; Causey PW
Appl Radiat Isot; 2020 Oct; 164():109262. PubMed ID: 32819503
[TBL] [Abstract][Full Text] [Related]
5. Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part I: purification of decayed thorium-227 on cation exchange columns.
Frenvik JO; Dyrstad K; Kristensen S; Ryan OB
Drug Dev Ind Pharm; 2017 Feb; 43(2):225-233. PubMed ID: 27628177
[TBL] [Abstract][Full Text] [Related]
6. Defining Processing Times for Accelerator Produced
Fitzsimmons J; Griswold J; Medvedev D; Cutler CS; Mausner L
Molecules; 2019 Mar; 24(6):. PubMed ID: 30897722
[TBL] [Abstract][Full Text] [Related]
7. Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part II: purification of targeted thorium conjugates on cation exchange columns.
Frenvik JO; Dyrstad K; Kristensen S; Ryan OB
Drug Dev Ind Pharm; 2017 Sep; 43(9):1440-1449. PubMed ID: 28402142
[TBL] [Abstract][Full Text] [Related]
8. New method for production of
Moiseeva AN; Aliev RA; Furkina EB; Novikov VI; Unezhev VN
Nucl Med Biol; 2022; 106-107():52-61. PubMed ID: 35032789
[TBL] [Abstract][Full Text] [Related]
9. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
10. Radiochemical separation of
Pruszyński M; Walczak R; Rodak M; Bruchertseifer F; Morgenstern A; Bilewicz A
Appl Radiat Isot; 2021 Jun; 172():109655. PubMed ID: 33657491
[TBL] [Abstract][Full Text] [Related]
11. Large scale accelerator production of
Griswold JR; Medvedev DG; Engle JW; Copping R; Fitzsimmons JM; Radchenko V; Cooley JC; Fassbender ME; Denton DL; Murphy KE; Owens AC; Birnbaum ER; John KD; Nortier FM; Stracener DW; Heilbronn LH; Mausner LF; Mirzadeh S
Appl Radiat Isot; 2016 Dec; 118():366-374. PubMed ID: 27776333
[TBL] [Abstract][Full Text] [Related]
12. Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy.
Hagemann UB; Wickstroem K; Hammer S; Bjerke RM; Zitzmann-Kolbe S; Ryan OB; Karlsson J; Scholz A; Hennekes H; Mumberg D; Cuthbertson AS
Cancer Biother Radiopharm; 2020 Sep; 35(7):497-510. PubMed ID: 32255671
[TBL] [Abstract][Full Text] [Related]
13. Development of separation technology for the removal of radium-223 from decayed thorium-227 in drug formulations. Material screening and method development.
Frenvik JO; Kristensen S; Ryan OB
Drug Dev Ind Pharm; 2016 Aug; 42(8):1215-24. PubMed ID: 26569601
[TBL] [Abstract][Full Text] [Related]
14. Chromatographic separation of the theranostic radionuclide
Mastren T; Radchenko V; Engle JW; Weidner JW; Owens A; Wyant LE; Copping R; Brugh M; Nortier FM; Birnbaum ER; John KD; Fassbender ME
Anal Chim Acta; 2018 Jan; 998():75-82. PubMed ID: 29153089
[TBL] [Abstract][Full Text] [Related]
15.
Robertson AKH; McNeil BL; Yang H; Gendron D; Perron R; Radchenko V; Zeisler S; Causey P; Schaffer P
Inorg Chem; 2020 Sep; 59(17):12156-12165. PubMed ID: 32677829
[TBL] [Abstract][Full Text] [Related]
16. Targeted Alpha Therapy with Thorium-227.
Frantellizzi V; Cosma L; Brunotti G; Pani A; Spanu A; Nuvoli S; De Cristofaro F; Civitelli L; De Vincentis G
Cancer Biother Radiopharm; 2020 Aug; 35(6):437-445. PubMed ID: 31967907
[TBL] [Abstract][Full Text] [Related]
17. Thorium chelators for targeted alpha therapy: Rapid chelation of thorium-226.
Ferrier MG; Li Y; Chyan MK; Wong R; Li L; Spreckelmeyer S; Hamlin DK; Mastren T; Fassbender ME; Orvig C; Wilbur DS
J Labelled Comp Radiopharm; 2020 Oct; 63(12):502-516. PubMed ID: 32812275
[TBL] [Abstract][Full Text] [Related]
18. Production of medical isotopes from a thorium target irradiated by light charged particles up to 70 MeV.
Duchemin C; Guertin A; Haddad F; Michel N; Métivier V
Phys Med Biol; 2015 Feb; 60(3):931-46. PubMed ID: 25574934
[TBL] [Abstract][Full Text] [Related]
19. The application of poorly crystalline silicotitanate in production of
Fitzsimmons J; Abraham A; Catalano D; Younes A; Cutler CS; Medvedev D
Sci Rep; 2019 Aug; 9(1):11808. PubMed ID: 31413268
[TBL] [Abstract][Full Text] [Related]
20. Selective separation of radium and actinium from bulk thorium target material on strong acid cation exchange resin from sulfate media.
McAlister DR; Horwitz EP
Appl Radiat Isot; 2018 Oct; 140():18-23. PubMed ID: 29936271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
